[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100518492":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":47,"collaborators":19,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":19,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":19,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":19,"overallStatus":33,"whyStopped":19,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Fudan University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Selective Lymph Node Dissection","EXPERIMENTAL","Selective Lymph Node Dissection is performed for cT1N0M0 Invasive Non-small Cell Lung Cancer With CTR\\>0.5 Located in the Apical Segment",[13],"Procedure: Selective Lymph Node Dissection",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"PROCEDURE","For patients with NSCLC with CTR\\>0.5 located in the apical segment, the inferior mediastinal lymph node was not need to dissected",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Haiquan Chen, M.D.","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},"Chaoqiang Deng, M.D.","CONTACT","+86-13122677592","fdudengcq@163.com",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Chaoqiang Deng","RECRUITING","Shanghai","Please Select","200032","China","CN",{"type":40,"coordinates":41},"Point",[42,43],121.45806,31.22222,{"lat":43,"lon":42},[46],{"name":32,"role":27,"phone":19,"phoneExt":19,"email":29},{"type":23,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Haiquan Chen","Director in the Department of Thoracic Surgery, FUSCC","100518492","phase-3-selective-lymph-node-dissection-for-ct1n0m0-invasive-nsclc-with-ctr05-located-in-the-apical-segment-ectop-1018-100518492",false,"NCT06031246","Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)","Selective Lymph Node Dissection for cT1N0M0 Invasive Non-small Cell Lung Cancer With CTR>0.5 Located in the Apical Segment: a Single-arm, Multi-center, Phase III Trial","Inclusion Criteria:\n\n1. Patients who sign the informed consent form and are willing to complete the study according to the plan;\n2. Aged from 18 to 80 years old;\n3. ECOG equals 0 or 1;\n4. Not receiving lung cancer surgery before;\n5. Resectable peripheral cT1N0M0 tumors with CTR\\>0.5 located in the apical segment;\n6. Non-lepidic predominant invasive NSCLC dignosed by frozen section;\n7. Not receiving chemotherapy or radiotherapy before.\n\nExclusion Criteria:\n\n1. Not cT1N0M0;\n2. Nodules not located in the apical segment or CTR≤0.5;\n3. Pre-invasive lung adenocarcinoma, lepidic predominant adenocarcinoma, or not lung adenocarcinoma diagnosed cytologically or pathologically;\n4. Receiving lung cancer surgery before;\n5. Receiving radiotherapy or chemotherapy.","ALL","18 Years","80 Years",{"count":61,"type":62},634,"ESTIMATED","INTERVENTIONAL",[65],"PHASE3","This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1018. The goal of this clinical trial is to confirm the theraputic effect of selective lymph node dissection for cT1N0M0 invasive non-small cell lung cancer with CTR\\>0.5 located in the apical segment. The main questions it aims to answer are:\n\nThe 5-year overall survival of patients having cT1N0M0 invasive non-small cell lung cancer with CTR\\>0.5 located in the apical segment; The post-operative lymph node metastasis and recurrence-free survival. Participants will receive selective lymph node dissection as the surgical procedure.",[68,69],"Lung Adenocarcinoma","Lymph Node Metastasis","2023-09-04",{"date":72,"type":73},"2023-09-11","ACTUAL",{"date":75,"type":73},"2023-04-01",{"date":77,"type":62},"2030-12-31",{"name":5,"class":6},1]